School of Materials Science and Engineering, Tongji University, Shanghai 201804, People's Republic of China.
Department of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, People's Republic of China.
Biomed Mater. 2024 May 9;19(4). doi: 10.1088/1748-605X/ad4220.
Artificial bone graft with osteoconductivity, angiogenesis, and immunomodulation is promising clinical therapeutics for the reluctant healing process of bone defects. Among various osteogenic substitutes, polymethyl methacrylate (PMMA) bone cement is a quit competitive platform due to its easy deployment to the bone defects with irregular shape and biomimetic mechanical properties. However, the biologically inert essence of PMMA is reliant on the passive osseointegration and cannot provide sufficient biologic cues to induce fast bone repair. Bioactive glass could serve as an efficient platform for the active osteogenesis of PMMA via ionic therapy and construction of alkaline microenvironment. However, the direct of deployment of bioactive glass into PMMA may trigger additional cytotoxicity and hinder cell growth on its surface. Hence we incorporated ionic therapy as osteogenic cue into the PMMA to enhance the biomedical properties. Specifically, we synthesized core-shell microspheres with a strontium-doped bioactive glass (SrBG) core and hydroxyapatite (HA) shell, and then composited them with PMMA to introduce multifunctional effects of HA incorporation, alkaline microenvironment construction, and functional ion release by adding microsphere. We preparedSrBG@HA/PMMA cements (= 30, 40, 50) with varied microsphere content and evaluated impacts on mechanical/handling properties, ion release, and investigated the impacts of different composite cements on proliferation, osteogenic differentiation, angiogenic potential, and macrophage polarization. These findings provide new perspectives and methodologies for developing advanced bone biomaterials to promote tissue regeneration.
具有骨传导性、血管生成和免疫调节作用的人工骨移植物是治疗骨缺损愈合不良的有前途的临床治疗方法。在各种成骨替代物中,聚甲基丙烯酸甲酯(PMMA)骨水泥因其易于应用于形状不规则和仿生力学性能的骨缺损而具有很强的竞争力。然而,PMMA 的生物惰性本质依赖于被动的骨整合,不能提供足够的生物线索来诱导快速的骨修复。生物活性玻璃可以作为 PMMA 主动成骨的有效平台,通过离子治疗和构建碱性微环境。然而,生物活性玻璃直接注入 PMMA 可能会引发额外的细胞毒性,并阻碍其表面的细胞生长。因此,我们将离子治疗作为成骨信号引入 PMMA 中,以增强其生物医学性能。具体来说,我们合成了具有掺锶生物活性玻璃(SrBG)核和羟基磷灰石(HA)壳的核壳微球,然后将其与 PMMA 复合,引入了 HA 掺入、碱性微环境构建和功能性离子释放的多功能效应。我们制备了 SrBG@HA/PMMA 水泥(= 30、40、50),其微球含量不同,并评估了它们对机械/处理性能、离子释放的影响,并研究了不同复合水泥对增殖、成骨分化、血管生成潜力和巨噬细胞极化的影响。这些发现为开发先进的骨生物材料以促进组织再生提供了新的视角和方法。